JB Chemicals Q4 Revenue Dips 5% Post-Torrent Acquisition

JB Chemicals reported Q4 FY26 revenue of INR 904 crores, a 5% YoY decline, following its acquisition by Torrent Pharma on January 21, 2026.
Adjusted for one-off costs of INR 40 crores, EBITDA was flat at INR 241 crores, with margins improving 200 bps to 27% and net profit at INR 150 crores.
Management outlined an operational reset in Q4, discontinuing low-margin trade generics and aligning practices, with normalization expected from Q1 FY27.
The merger with Torrent Pharma is in its final stages, with a hearing scheduled for the second week of June 2026.